Lifespot Health logo

LSH - Lifespot Health Share Price

A$0.049 0.0  0.0%

Last Trade - 24/09/20

Sector
Healthcare
Size
Micro Cap
Market Cap £2.64m
Enterprise Value £2.37m
Revenue £84.5k
Position in Universe 1747th / 1829
Bullish
Bearish
Unlock LSH Revenue
Momentum
Relative Strength (%)
1m +31.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -33.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.001 0.54 0.43 0.15 +487.5%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Lifespot Health Ltd revenues decreased 97% to A$3K. Net loss decreased 55% to A$466K. Revenues reflect Revenue and income decrease of 96% to A$3K, Other Business Related Financing Revenue decrease from A$17K to A$0K. Lower net loss reflects Employee benefits expense decrease of 86% to A$28K (expense), Travel Expenses decrease of 99% to A$1K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

LSH Revenue Unlock LSH Revenue

Net Income

LSH Net Income Unlock LSH Revenue

Normalised EPS

LSH Normalised EPS Unlock LSH Revenue

PE Ratio Range

LSH PE Ratio Range Unlock LSH Revenue

Dividend Yield Range

LSH Dividend Yield Range Unlock LSH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
LSH EPS Forecasts Unlock LSH Revenue
Profile Summary

Lifespot Health Ltd. operates within the digital health sector. The Company is focused on developing and commercializing medical diagnostic and monitoring technology, which includes the BodyTel System and the Lifespot Skin System. The BodyTel System is a system that facilitates the management of chronic diseases and assists with the measurement of vital functions and indicators of these diseases (including blood glucose, blood pressure and weight levels), as well as assisting with the monitoring of prescribed therapies for chronic diseases (including medication dosages, diets and levels of physical activity). The BodyTel System involves various components, which include The BodyTel Sensor, The BodyTel App, The BodyTel backend system and The BodyTel Webportal. Its Lifespot Skin System is being developed and will operate through the Lifespot Skin mobile application. It is developing digital healthcare solutions to assist doctors and empower patients to diagnose and manage skin diseases.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated April 13, 2016
Public Since January 11, 2017
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 96,788,303
Free Float (0.0%)
Eligible for
ISAs
SIPPs
LSH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for LSH
Upcoming Events for LSH
Frequently Asked Questions for Lifespot Health
What is the Lifespot Health share price?

As of 24/09/20, shares in Lifespot Health are trading at A$0.049, giving the company a market capitalisation of £2.64m. This share price information is delayed by 15 minutes.

How has the Lifespot Health share price performed this year?

Shares in Lifespot Health are currently trading at A$0.049 and the price has moved by -10.91% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Lifespot Health price has moved by 0.24% over the past year.

What are the analyst and broker recommendations for Lifespot Health?

There are no analysts currently covering Lifespot Health.

When will Lifespot Health next release its financial results?

Lifespot Health is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Lifespot Health dividend yield?

Lifespot Health does not currently pay a dividend.

Does Lifespot Health pay a dividend?

Lifespot Health does not currently pay a dividend.

When does Lifespot Health next pay dividends?

Lifespot Health does not currently pay a dividend.

How do I buy Lifespot Health shares?

To buy shares in Lifespot Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Lifespot Health?

Shares in Lifespot Health are currently trading at A$0.049, giving the company a market capitalisation of £2.64m.

Where are Lifespot Health shares listed? Where are Lifespot Health shares listed?

Here are the trading details for Lifespot Health:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: LSH
What kind of share is Lifespot Health?

Based on an overall assessment of its quality, value and momentum, Lifespot Health is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Lifespot Health share price forecast 2020?

We were not able to load any forecast data for Lifespot Health.

How can I tell whether the Lifespot Health share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lifespot Health. Over the past six months, the relative strength of its shares against the market has been -26.28%. At the current price of A$0.049, shares in Lifespot Health are trading at 14.22% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Lifespot Health PE Ratio?

We were not able to find PE ratio data for Lifespot Health.

Who are the key directors of Lifespot Health?

Lifespot Health's management team is headed by:

Francesco Cannavo - NED
Justyn Stedwell - SEC
Stefan Schraps - CEO
Rodney Hannington - NEC
Who are the major shareholders of Lifespot Health?

Here are the top five shareholders of Lifespot Health based on the size of their shareholding:

Lifespot Capital AG Corporation
Percentage owned: 9.42% (9.20m shares)
Pyxis Holdings Pty. Ltd. Corporation
Percentage owned: 8.24% (8.05m shares)
Orca Capital GmbH Investment Advisor
Percentage owned: 6.48% (5.68m shares)
Peak Asset Management Pty. Ltd. Investment Advisor
Percentage owned: 3.8% (3.71m shares)
10 Bolivianos Pty. Ltd. Corporation
Percentage owned: 2.75% (2.69m shares)
Similar to LSH
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.